PEOPLE TAKING GLP-1S have a reduced risk of heart attacks, strokes, and death from cardiovascular disease, according to a ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Researchers at the University of Basel are able to test in parallel the effects of over 1,500 active substances on cell ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

If your constipation lasts for more than three days, speak with your doctor about options to help. You might need to add a ...

Glucagon-like peptide 1 receptor agonists (GLP1RA)—medications for type 2 diabetes and obesity that have recently been making ...

Glucagon-like peptide 1 receptor agonists (GLP1RA)—medications for type 2 diabetes and obesity that have recently been making ...

among other body functions. Olanzapine can cause mild and serious side effects. These may be the same or different in a person who doesn’t have a mental health condition the drug is used to treat.

during the first week or two of taking the drug. These side effects should go away as your body adjusts to the medication. Long-term side effects from fluoxetine can also occur but aren’t common.

Most people know that GLP-1 receptor agonist medications like Ozempic and Wegovy can cause relatively minor side effects like ...

A large study published in Nature Medicine reviewed the effects of GLP-1 drugs like Ozempic and Mounjaro on 175 different ...